JS

Jeffrey Schlom

US US Dept of Health & Human Services: 25 patents #9 of 3,044Top 1%
GL Globeimmune: 15 patents #5 of 23Top 25%
The Dow Chemical: 5 patents #698 of 4,115Top 20%
TB Therion Biologics: 4 patents #6 of 14Top 45%
NI NIH: 1 patents #22 of 259Top 9%
DI Dana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
📍 Potomac, MD: #6 of 998 inventorsTop 1%
🗺 Maryland: #77 of 35,612 inventorsTop 1%
Overall (All Time): #20,007 of 4,157,543Top 1%
85
Patents All Time

Issued Patents All Time

Showing 51–75 of 85 patents

Patent #TitleCo-InventorsDate
7763719 Variants of humanized anti-carcinoma MAb CC49 Syed V. S. Kashmiri, Eduardo A. Padlan 2010-07-27
7723096 Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides Elene Barzaga, Sam Zaremba 2010-05-25
7709002 Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes Scott Abrams 2010-05-04
7662395 Method of enhancing a targeted immune response against tumors Judith Kantor, James Hodge 2010-02-16
7598225 Generation of immune response to prostate-specific antigen (PSA) Dennis L. Panicali 2009-10-06
7589181 Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use Syed V. S. Kashmiri, Eduardo A. Padlan 2009-09-15
7569673 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors Syed V. S. Kashmiri, Eduardo A. Padlan 2009-08-04
7547773 Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides Kwong-Yok Tsang, Sam Zaremba 2009-06-16
7410644 Recombinant pox virus for immunization against tumor-associated antigens Dennis L. Panicali, Linda R. Gritz, Gail P. Mazzara 2008-08-12
7368116 Method of enhancing a targeted immune response against tumors Judith Kantor, James Hodge 2008-05-06
7256004 Variants of humanized anti-carcinoma monoclonal antibody CC49 Syed V. S. Kashmiri, Eduardo A. Padlan 2007-08-14
7247615 Peptide agonists of prostate-specific antigen and uses therefor Kwong-Yok Tsang 2007-07-24
7211432 Recombinant vector expressing multiple costimulatory molecules and uses thereof James Hodge, Dennis L. Panicali 2007-05-01
7179899 Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72 Peter Mezes, Ruth A. Richard, Kimberly Johnson, Syed V. S. Kashmiri, Liming Shu +1 more 2007-02-20
7118738 Recombinant pox virus for immunization against MUC1 tumor-associated antigen Judith Kantor, Donald W. Kufe, Dennis L. Panicali, Linda R. Gritz 2006-10-10
6969609 Recombinant vector expressing multiple costimulatory molecules and uses thereof James Hodge, Dennis L. Panicali 2005-11-29
6946133 Prostate specific antigen oligo-epitope peptide Kwong-Yok Tsang, Sam Zaremba 2005-09-20
6893869 Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule Judith Kantor, James Hodge 2005-05-17
6818749 Variants of humanized anti carcinoma monoclonal antibody cc49 Syed V. S. Kashmiri, Eduardo A. Padlan 2004-11-16
6756038 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) Elene Barzaga, Sam Zaremba 2004-06-29
6548068 Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule Judith Kantor, James Hodge 2003-04-15
6495137 Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains Peter Mezes, Ruth A. Richard, Kimberly Johnson, Syed V. S. Kashmiri, Liming Shu +1 more 2002-12-17
6319496 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof Dennis L. Panicali 2001-11-20
6207815 Family of high affinity, modified antibodies for cancer treatment Peter Mezes, Brian B. Gourlie, Mark W. Rixon, Donald A. Kaplan, W. H. Kerr Anderson 2001-03-27
6165460 Generation of immune responses to prostate-specific antigen (PSA) Dennis L. Panicali 2000-12-26